Volume 48, Number 12, 614-621, DOI: 10.1007/s10038-003-0087-2

Combined effects of PPAR?2 P12A and PPARa L162V polymorphisms on glucose and insulin homeostasis: the Québec Family Study

Yohan Bossé, S.John Weisnagel, Claude Bouchard, Jean-Pierre Després, Louis Pérusse and Marie-Claude Vohl

View Related Documents

Abstract

Peroxisome proliferator-activated receptors gamma2 and agr are nuclear factors known to be important regulators of lipid and glucose metabolism. Two polymorphisms, namely PPARgamma2 P12A and PPARagr L162V, were investigated for their individual and interaction effects on glucose and insulin homeostasis. Genotypes were determined in 663 nondiabetic adults participating in the Québec Family Study and who underwent an oral glucose tolerance test (OGTT). The insulin and C-peptide areas under the curve (AUC) following the OGTT were higher in subjects carrying the PPARagr V162 allele compared to homozygous for the L162 allele. When subjects were grouped according to both polymorphisms, higher levels of insulin and C-peptide during the OGTT were observed for those carrying the PPARagr V162 allele except when they carry at the same time the PPARgamma2 A12 allele. Thus, the PPARgamma2 A12 allele seems protective against the deleterious effect of the PPARagr V162 allele. Furthermore, a significant gene-gene interaction was observed for the acute (0–30 min) (p<0.001) and the total (p=0.05) C-peptide AUC following the OGTT. These results provide evidence of a gene-gene interaction in the regulation of plasma glucose-insulin homeostasis, and emphasize that these interactions need to be taken into account when dissecting the genetic etiology of complex disorders.

Keywords  Peroxisome proliferator-activated receptors - OGTT - Epistasis - Type 2 diabetes - C-peptide - Insulin homeostasis - PPARgamma2 P12A mutation - PPARagr L162V mutation

Fulltext Preview

Image of the first page of the fulltext document